Systemic Factors Associated with Treatment Response in Diabetic Macular Edema.
Wendy Meihua WongCaroline CheeMayuri BhargavaCharmaine ChaiHazel LinPaul ZhaoErlangga Ariadarma MangunkusumoThet NaingYew Sen YuenTien Yin WongXinyi SuLingam GopalPublished in: Journal of ophthalmology (2020)
Better glycemic control is associated with a greater reduction in central macular thickness after the first injection of bevacizumab or ranibizumab in diabetic macular edema. Patients with high levels of HbA1c and poor response to anti-VEGF may benefit from strict control of their blood glucose.
Keyphrases
- glycemic control
- blood glucose
- optical coherence tomography
- diabetic retinopathy
- age related macular degeneration
- type diabetes
- vascular endothelial growth factor
- endothelial cells
- weight loss
- insulin resistance
- metastatic colorectal cancer
- ultrasound guided
- adipose tissue
- blood pressure
- metabolic syndrome
- skeletal muscle